Atlas Trials

Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC)

Clinical trial NCT03544736 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03544736
Sponsor
Oslo University Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2018-04-26
Primary completion
2025-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.